Matthew Sarb, DO
Orthopaedic Surgery · Dickson, TNNPI 1407045230
Payments from drug & device makers
Across 102 payments — averaging $52.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$2K
- Ortho Development Corporation$1K
- Amgen$334
- Alpha Orthopedic Systems$182
- Endo Pharmaceuticals Inc.$155
- Pacira Therapeutics, Inc.$152
- plus $1K from 29 others
What the payments were for
- Speaking & faculty fees$1,50028%
- Travel & lodging$1,45027%
- Food & beverage$2,35844%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 3 | $2,043 |
| Ortho Development Corporation | 4 | $1,049 |
| Amgen | 18 | $334 |
| Alpha Orthopedic Systems | 3 | $182 |
| Endo Pharmaceuticals Inc. | 9 | $155 |
| Pacira Therapeutics, Inc. | 8 | $152 |
| Smith+Nephew | 5 | $142 |
| Stryker | 5 | $101 |
| Vertex | 3 | $95 |
| Arthrosurface Incorporated | 1 | $92 |
| Sonex Health, Inc. | 3 | $89 |
| Kerecis Limited | 1 | $89 |
| Endo USA, Inc. | 4 | $88 |
| Radius Health, Inc. | 4 | $80 |
| Johnson & Johnson | 3 | $63 |
| DJO, LLC | 3 | $54 |
| Avanos Medical | 2 | $43 |
| Polynovo North America LLC | 1 | $41 |
| Skeletal Dynamics Inc | 1 | $40 |
| Pacira Pharmaceuticals Incorporated | 2 | $39 |
| Integra Lifesciences Corporation | 1 | $38 |
| Bioventus LLC | 2 | $38 |
| Fidia Pharma USA Inc. | 2 | $36 |
| Anika Therapeutics, Inc. | 1 | $29 |
| Convatec Inc. | 1 | $27 |
| Illuminoss Medical, Inc. | 2 | $26 |
| Orthofix Medical, Inc. | 2 | $19 |
| Neuros Medical, Inc. | 1 | $19 |
| Linvatec Corporation | 1 | $17 |
| Music City Medical Technologies, LLC | 1 | $16 |
| Triad Life Sciences Inc. | 1 | $16 |
| Paragon 28, Inc. | 1 | $15 |
| Acera Surgical, Inc. | 1 | $15 |
| Orthogenrx Inc. | 1 | $14 |
| Acell, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,308 in reported general payments places this provider in the 55th percentile of 381 orthopaedic surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 13 | $7,247 |
| Celecoxib | 553 | $6,260 |
| Meloxicam | 929 | $2,390 |
| Methylprednisolone | 180 | $1,292 |
| Diclofenac Sodium | 37 | $1,134 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 111 | $1,039 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $377 |
| Rifampin | 12 | $264 |
| Cephalexin | 43 | $197 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $185 |
| Tramadol Hcl | 82 | $183 |
| Ibuprofen | 27 | $145 |
| Mupirocin | 19 | $131 |
| Gabapentin | 11 | $45 |
| Furosemide | 22 | $34 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $63 | $7,24713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 381 orthopaedic surgery providers in Tennessee.
Other orthopaedic surgery in Dickson
- Paul BradyKnoxville$20.1M
- Jesse DotyChattanooga$2.5M
- Edwin SpencerKnoxville$2.5M
- Thomas ThrockmortonGermantown$1.9M
- Tyler BrolinCollierville$1M
- Jefferson MorrisonNashville$910K
- Matthew WillisNashville$850K
- Alton HunterColumbia$820K
- David DeboerNashville$746K
- Michael BeebeMemphis$679K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.